GURUFOCUS.COM » STOCK LIST » Healthcare » Biotechnology » Devonian Health Group Inc (TSXV:GSD) » Definitions » 3-Year EPS without NRI Growth Rate

Devonian Health Group (TSXV:GSD) 3-Year EPS without NRI Growth Rate : 38.90% (As of Oct. 2024)


View and export this data going back to 2014. Start your Free Trial

What is Devonian Health Group 3-Year EPS without NRI Growth Rate?

Devonian Health Group's EPS without NRI for the three months ended in Oct. 2024 was C$-0.00.

During the past 3 years, the average EPS without NRI Growth Rate was 38.90% per year. During the past 5 years, the average EPS without NRI Growth Rate was 27.90% per year. Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.

During the past 11 years, the highest 3-Year average EPS without NRI Growth Rate of Devonian Health Group was 38.90% per year. The lowest was 11.20% per year. And the median was 15.00% per year.


Competitive Comparison of Devonian Health Group's 3-Year EPS without NRI Growth Rate

For the Biotechnology subindustry, Devonian Health Group's 3-Year EPS without NRI Growth Rate, along with its competitors' market caps and 3-Year EPS without NRI Growth Rate data, can be viewed below:

* Competitive companies are chosen from companies within the same industry, with headquarter located in same country, with closest market capitalization; x-axis shows the market cap, and y-axis shows the term value; the bigger the dot, the larger the market cap. Note that "N/A" values will not show up in the chart.


Devonian Health Group's 3-Year EPS without NRI Growth Rate Distribution in the Biotechnology Industry

For the Biotechnology industry and Healthcare sector, Devonian Health Group's 3-Year EPS without NRI Growth Rate distribution charts can be found below:

* The bar in red indicates where Devonian Health Group's 3-Year EPS without NRI Growth Rate falls into.


;
;

Devonian Health Group 3-Year EPS without NRI Growth Rate Calculation

This is the 3-year average growth rate of EPS without NRI. The growth rate is calculated using exponential compounding based on the latest four year annual data.

Please click Growth Rate Calculation Example (GuruFocus) to see how GuruFocus calculates Wal-Mart Stores Inc (WMT)'s revenue growth rate. You can apply the same method to get the average EPS without NRI growth rate.


Devonian Health Group  (TSXV:GSD) 3-Year EPS without NRI Growth Rate Explanation

EPS without NRI is the amount of earnings without non-recurring items per outstanding share of the company's stock.

Earnings Per Share (EPS) is the single most important variable used by Wall Street in determining the earnings power of a company. But investors need to be aware that Earnings per Share can be easily manipulated by adjusting depreciation and amortization rate or non-recurring items. That's why GuruFocus lists Earnings per share without Non-Recurring Items, which better reflects the company's underlying performance.


Devonian Health Group 3-Year EPS without NRI Growth Rate Related Terms

Thank you for viewing the detailed overview of Devonian Health Group's 3-Year EPS without NRI Growth Rate provided by GuruFocus.com. Please click on the following links to see related term pages.


Devonian Health Group Business Description

Industry
Traded in Other Exchanges
Address
360, Rue des Entrepreneurs, Montmagny, QC, CAN, G5V 4T1
Devonian Health Group Inc is operating in the pharmaceutical sector. It is engaged in the development and distribution of botanical drugs. The group is also involved in the development of value-added products for dermo-cosmetics. It has established a research effort focused on the anticipation of new solutions in the medical sector as well as in the cosmetic sector. The company's technology platform, The Supra Molecular Complex Extraction and Stabilization Technology provides a process of extraction, purification, stabilization, and conditioning of molecular complexes, as active botanical ingredients, from plants and algae. Its product portfolio includes pharmaceuticals like Thykamine, Pantoprazole, and Cleo-35; and cosmeceutical products like R-Spinasome and Purgenesis.

Devonian Health Group Headlines

No Headlines